Clinical Trial Update: Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes [Phase 2]

View source ↗

Summary

Phase 2 study of KLS-0611 for dry eye syndromes has completed; the snippet does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• KLS-0611

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED